Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

Clinical trial NCT07520006 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07520006
Sponsor: Nurix Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Start date: 2026-05-01
Primary completion: 2033-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.